Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jerry Y. Hsu"'
Autor:
Shuguang Ma, Sungjoon Cho, Srikumar Sahasranaman, Weiping Zhao, Jodie Pang, Xiao Ding, Brian Dean, Bin Wang, Jerry Y. Hsu, Joseph Ware, Laurent Salphati
Publikováno v:
Drug Metabolism and Disposition. 51:436-450
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdf16c475c39101aef67df335d26c42f
https://doi.org/10.1124/dmd.122.001096
https://doi.org/10.1124/dmd.122.001096
Autor:
José Baselga, Daniel D. Von Hoff, Jerry Y. Hsu, Hema Parmar, Huan Jin, Ray S. Lin, Laurent Salphati, Deepak Sampath, Heidi M. Savage, Sandra M. Sanabria Bohorquez, Joseph A. Ware, Timothy R. Wilson, Ramesh K. Ramanathan, Ian Krop, Dejan Juric
Supplementary Table S1. Patient Demographics and Disease Characteristics. Supplementary Table S2. Treatment-Related Adverse Events of Grade 3 or Higher Observed in either Cycle 1 or Cycle greater than or equal to 2. Supplementary Table S3. Adverse Ev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08231e12877ec97d91ac400e1e431122
https://doi.org/10.1158/2159-8290.22532083.v1
https://doi.org/10.1158/2159-8290.22532083.v1
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Study disposition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54688aa6bdc19b53f7e66ca2401b9476
https://doi.org/10.1158/1078-0432.22470125
https://doi.org/10.1158/1078-0432.22470125
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Adverse events (AEs) of special interest in the safety population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae6acd8abd9056f54efcd64e4886486
https://doi.org/10.1158/1078-0432.22470119
https://doi.org/10.1158/1078-0432.22470119
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Participant PIK3CA-mutation central testing results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2863ddcb43ff59658511ba8e4758454e
https://doi.org/10.1158/1078-0432.22470131.v1
https://doi.org/10.1158/1078-0432.22470131.v1
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Clinical activity in patients with and without measurable disease at baseline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f29410bfab495ae5608935e0bed6cca
https://doi.org/10.1158/1078-0432.22470113.v1
https://doi.org/10.1158/1078-0432.22470113.v1
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Time on treatment by taselisib dose and duration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::746bc55763b1466342d2c810d4279f5b
https://doi.org/10.1158/1078-0432.22470128.v1
https://doi.org/10.1158/1078-0432.22470128.v1
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Serious adverse events (SAEs) regardless of attribution in the safety population
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::899b1584587fb9b45f139d4eff2867e4
https://doi.org/10.1158/1078-0432.22470122.v1
https://doi.org/10.1158/1078-0432.22470122.v1
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Purpose: This single-arm, open-label phase II study evaluated the safety and efficacy of taselisib (GDC-0032) plus fulvestrant in postmenopausal women with locally advanced or metastatic HER2-negative, hormone receptor (HR)-positive breast cancer.Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bcfa6f15e33353fab87b74f809dce14
https://doi.org/10.1158/1078-0432.c.6527435
https://doi.org/10.1158/1078-0432.c.6527435
Autor:
José Baselga, Jerry Y. Hsu, Michael C. Wei, Thomas J. Stout, Timothy R. Wilson, Na Cui, Alison K. Cardenas, Mafalda Oliveira, Lajos Pusztai, Manish R. Patel, Philippe L. Bedard, Andrés Cervantes, Ian E. Krop, Donald A. Richards, Cristina Saura, Maura N. Dickler
Definition of adverse events of special interest (AESI)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cefcb97387728d98ee62316ec97bda0
https://doi.org/10.1158/1078-0432.22470134
https://doi.org/10.1158/1078-0432.22470134